Results 161 to 170 of about 1,272 (174)

BODY COMPOSITION AND METABOLIC CHANGES IN VLCKD: AN UPDATE

Nutrition, 2019
VLCKD is becoming an elective choice to promote weight loss, especially in the case of severe obesity and its metabolic complications. Some authors have assumed that VLCKD can better pre­serve lean body mass during weight loss, saving from diet-induced sarcopenia. BIA evaluation is a simple method to estimate body compostion. At the Maggiore Hospital
G. Corbelli, L. Valeriani, F. Anzolin, G. Tommesani, M. Fornari, M.G. Benassi, B. Corradini, L. Morisi, L. Zoni   +8 more
openaire   +1 more source

Killing three birds with one stone: VLCKD in a female patient with obesity, celiac disease and migraine

Progress in Nutrition, 2022
Very Low-Calorie Ketogenic Diets (VLCKD) are indicated as a valid tool to treat morbid obesity. Growing evidence suggests an association between overweight/obesity and migraine symptoms and shows how a weight reduction improve pain and headache in these patients.
Vigna, Luisella, Tomaino, Laura, Lotito, Veronica, Di Pierro, Francesco, Ingenito, Maria Rosaria, Sommaruga, Daniela, Piontini, Alessandra, Marsili, Alessandro   +7 more
openaire   +1 more source

Efficacy of the Very Low-Calorie Ketogenic Diet (VLCKD) in postmenopausal women with obesity: better to be “owls” or “larks”?

Maturitas, 2023
Ludovica Verde, Annamaria Docimo, Giovanni Battista Chirico, Nicola Tecce, Annamaria Colao, Luigi Barrea, Giovanna Muscogiuri   +6 more
openalex   +2 more sources

Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis

Reviews in Endocrine and Metabolic Disorders, 2019
Very low calorie ketogenic diet (VLCKD) has been proposed as a promising option to achieve a significant weight loss in a short time period. We conducted a systematic review and meta-analysis to evaluate its efficacy and safety in patients with overweight and obesity. Four databases were searched on May 2019. Studies reporting data on body weight, body
Marco Castellana, Eleonora Conte, Angelo Cignarelli, Sebastio Perrini, Andrea Giustina, Luca Giovanella, Francesco Giorgino, Pierpaolo Trimboli   +7 more
openalex   +4 more sources

VLCKD improves MASLD and metabolic dysfunction in patients with type 2 diabetes and obesity

Endocrine Abstracts
Sabrina Tini, Shivaun A. Celano, Jessica Baima, Valentina Antoniotti, Alessandro Antonioli, Maria Mollero Edoardo Luigi, Daniele Spadaccini, Paolo Marzullo, Sacchetti Gian Mauro, Gianluca Aimaretti, Flavia Prodam   +10 more
openalex   +2 more sources

Very-low-calorie-ketogenic-diet (VLCKD) as a nutritional therapeutical option for chronic management in obese patients with type 2 diabetes: a case report

Endocrine Abstracts, 2023
Chiara Parazzoli, Graziella Volpi, Paola Silvia Morpurgo, Alessandra Gandolfi, Bolla Andrea Mario, Paolo Fiorina   +5 more
openalex   +2 more sources

Comment on “Chronotype as a predictor of weight loss and body composition improvements in women with overweight or obesity undergoing a very low-calorie ketogenic diet (VLCKD)” clinical nutrition 2023

Clinical Nutrition, 2023
Ingrid Thayanne Souza Alves da Silva, Débora Eduarda da Silva Fidelis, Matheus Santos de Sousa Fernandes   +2 more
openalex   +3 more sources

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)

Journal of Endocrinological Investigation, 2019
Weight loss is a milestone in the prevention of chronic diseases associated with high morbility and mortality in industrialized countries. Very-low calorie ketogenic diets (VLCKDs) are increasingly used in clinical practice for weight loss and management of obesity-related comorbidities.
Massimiliano Caprio, Marco Infante, Eleonora Moriconi, Andrea Armani, Andrea Fabbri, Giovanna Mantovani, Stefania Mariani, Carla Lubrano, Eleonora Poggiogalle, Silvia Migliaccio, Lorenzo M. Donini, Sabrina Basciani, Angelo Cignarelli, Eleonora Conte, Giovanni Ceccarini, Fausto Bogazzi, Laura Cimino, Rosita A. Condorelli, Sandro La Vignera, Aldo E. Calogero, Alessandra Gambineri, Linda Vignozzi, Flavia Prodam, Gianluca Aimaretti, Giuseppe Linsalata, Simona Buralli, Fabio Monzani, Antônio Aversa, Roberto Vettor, Ferruccio Santini, Paolo Vitti, Lucio Gnessi, Uberto Pagotto, Francesco Giorgino, Annamaria Colao, Andrea Lenzi, Massimiliano Caprio, Fausto Bogazzi, Guglielmo Beccuti, Bernadette Biondi, Salvatore Cannavò, Iacopo Chiodini, Giuseppe De Feudis, Simona Di Francesco, Aldo Di Gregorio, Francesco Fallo, Carlo Foresta, Gilberta Giacchetti, Riccarda Granata, Andrea M. Isidori, Paolo Magni, Pasquale Maiellaro, Mirko Parasiliti‐Caprino, Rosario Pivonello, Riccardo Pofi, Alfredo Pontecorvi, Chiara Simeoli, Chiara Simeoli   +57 more
openalex   +10 more sources

Serum Oxytocin predicts body dysmorphic concerns and ketosis occurrence in patients withobesity on a VLCKD

Endocrine Abstracts
Rebecca Rossetti, Rossella Tozzi, Davide Masi, Curreli Maria Ignazia, Sabrina Basciani, Spoltore Maria Elena, Elena Gangitano, Paola Nevi, Orietta Gandini, Vittoria Strinati, Massari Maria Chiara, Mikiko Watanabe, Stefania Mariani, Lucio Gnessi, Carla Lubrano   +14 more
openalex   +2 more sources

[VLCD and VLCKD in the treatment of obese people with non-insulin-dependent diabetes or prediabetes: clinical evidence and reflections.]

Recenti progressi in medicina, 2022
The dramatic rise in the prevalence of obesity and diabetes has become a major global public health issue. "Prediabetes" is the term used for individuals whose glucose levels do not meet the criteria for diabetes but are too high to be considered normal.
openaire   +1 more source